Ask AI
ProCE Banner Activity

Expert Guidance in Alpha-1 Antitrypsin Deficiency: Why Early Detection and Multidisciplinary Management Are Key

Podcast Episodes

Listen in as 4 experts discuss their current screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including the necessary role of multidisciplinary care and early detection to improve outcomes.

Released: May 09, 2025

Expiration: May 08, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Disclosure

Primary Author

Paula Henao, MD, has no relevant financial relationships to disclose.

Rohit Loomba, MD, MHSc: consultant/advisor/speaker: 89Bio, Aardvark, Altimmune, Arrowhead, AstraZeneca, Cascade, Gilead, Glympse Bio, Inipharma, Intercept, Inventiva, Ionis, Janssen, Lilly, Lipidio, Madrigal, Merck, Neurobo, Novo Nordisk, Pfizer, Sagimet, Takeda, Terns, Viking; stock options: Sagimet Biosciences; research grants paid to institution: Arrowhead, Astrazeneca, Boehringer Ingelheim, Bristol Myers Squibb, Galectin, Gilead, Hanmi, Intercept, Inventiva, Ionis, Janssen, Lilly, Madrigal, Merck, Novo Nordisk, Pfizer, Sonic Incytes, Terns; co-founder: LipoNexus.

Cheryl Pirozzi, MD, MS: researcher (paid to institution): AstraZeneca, Inhibrx, Vertex; consultant/advisor/speaker: CSL Vifor.

Corinne Young, NP, FCCP: consultant/advisor/speaker: GlaxoSmithKline, Grifols, Regeneron/Sanofi.